Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
27 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/27/3033525/0/en/Significant-milestone-reached-for-EG-427-with-first-patient-treated-with-EG110A-first-non-replicative-herpes-vector-based-genetic-medicine-for-the-treatment-of-neurogenic-bladder.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/20/3029316/0/en/EG-427-raises-27-million-in-successful-Series-B-co-led-by-Andera-Partners-and-Bpifrance-to-finance-on-going-clinical-study-and-platform-development.html
24 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/24/2902739/0/en/First-gene-therapy-for-prevalent-pathologies-in-neurology-receives-FDA-IND-clearance-EG-427-initiating-first-in-human-clinical-study.html
04 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/01/04/2803917/0/en/EG427-Announces-New-Preclinical-Results-from-Multiple-Studies-of-EG110A-in-Neurogenic-Detrusor-Overactivity-NDO-and-Overactive-Bladder-OAB.html
13 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/13/2704058/0/en/EG-427-announces-final-Series-A-closing-achieving-18-million-in-total-funds-raised.html
ABOUT THIS PAGE